
A multicenter randomized trial exploring the efficacy of cervical pessary in preventing preterm birth before 32 weeks in monochorionic diamniotic twin pregnancies following laser treatment for twin-twin transfusion syndrome was halted prematurely due to futility. Among 137 participants, no significant difference was found in preterm birth rates between those with pessary placement (40.3%) and conservative management (35.7%). Overall survival and neonatal outcomes also showed no significant variance. The study concludes that, in these cases, routine use of cervical pessary did not reduce preterm delivery before 32 weeks.
Like
Save
Share